Exit-site infection in CAPD: a review.
Luzar
M A
MA
Baxter R&D Europe, Nivelles, Belgium.
D001424:Bacterial Infections / Q000382:microbiology / Q000517:prevention & control; D002353:Carrier State; D006801:Humans; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects* / Q000295:instrumentation; D013203:Staphylococcal Infections